GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
P

Pharmicell Co 005690.KS · KRW

Health Care · KRX · 🇰🇷 South Korea

Compare

8,030

+0.88%

Close of 9 Nov 2026, in KRW

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Analyst ratings

5 analysts, 1 Mar 2026. The analysts' own views, not ours.

  • 1Strong buy
  • 3Buy
  • 1Hold
  • 0Sell
  • 0Strong sell

Price targets

Brokers' own targets, 21 Feb 2026. Not our view.

Average target 16,830

Low
16,665
Average
16,830
Median
16,830
High
17,325

Forecasts

Analyst averages for the fiscal years ahead

FY2026FY2027
Revenue₩160.00bn₩230.00bn
Revenue, highest₩160.00bn₩230.00bn
Revenue, lowest₩160.00bn₩230.00bn
Earnings per share987.001221.00
Earnings per share, highest987.001221.00
Earnings per share, lowest987.001221.00
Analysts11

Earnings against forecasts

Earnings per share by fiscal quarter

Q2 2026Q1 2026Q4 2025
Forecast213.00203.00262.00
Reported172.96195.10262.00
Difference-18.8%-3.9%0.0%

Quality and value scores

Models run by our data supplier, not our view and not investment advice

Model

Quality score

7 / 10

Revenue growth 16.3% a year over 10 years. Return on equity 32.5%.

Model fair value

33,992.56

From earnings 33,992.56, from revenue 14,760.37.

Piotroski score

7 / 9

A nine-point test of financial strength, for 31 Dec 2025.

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.